Edition:
United States

Formycon AG (FYB.DE)

FYB.DE on Xetra

37.75EUR
6:21am EDT
Change (% chg)

€0.55 (+1.48%)
Prev Close
€37.20
Open
€38.00
Day's High
€38.00
Day's Low
€37.30
Volume
716
Avg. Vol
5,417
52-wk High
€39.38
52-wk Low
€28.20

Select another date:

Mon, May 7 2018

BRIEF-Formycon FY Net Loss Of EUR 1.58 Mln

* INCREASED FY TURNOVER BY A GOOD 48 PERCENT COMPARED TO PREVIOUS YEAR TO EURO 29.00 MILLION (2016: 19.53 MILLION)

BRIEF-Formycon Says Biosimilar Candidate FYB201 Shows Efficacy Comparable To Reference Product In Phase III Study

* BIOSIMILAR CANDIDATE FYB201 SHOWS EFFICACY COMPARABLE TO REFERENCE PRODUCT IN PHASE III STUDY Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Formycon And Aristo Pharma Are Founding Joint Venture For Development Of FYB202

* PTA-ADHOC: FORMYCON AG: FORMYCON AND ARISTO PHARMA ARE FOUNDING A JOINT VENTURE FOR THE DEVELOPMENT OF FYB202

BRIEF-Formycon 9-month Net Loss at 5.11 Million Euros

* REPORTS OPERATING AND FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2017

Select another date: